Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378649969> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4378649969 abstract "Introduction: While better known for its pulmonary symptoms, SARS-CoV-2 also adversely affects the gastrointestinal tract, causing diarrhoea with evidence of inflammation. The nuclear bile acid receptor, farnesoid x receptor (FXR), is expressed in colonic epithelial cells and has been previously shown to inhibit cytokine production and promote barrier function, thereby preventing inflammatory responses in the gut. In the current studies, we set out to investigate a potential role for FXR in modulating epithelial responses to SARS-CoV-2. Methods: Undifferentiated human colonic or ileal enteroids, colonic epithelial T 84 , or Caco-2 cells were all grown as monolayers on permeable supports. Cells were treated with the FXR agonists, obeticholic acid (OCA, 10 μM) or GW4064 (5 μM), or infected with live SARS-CoV-2 (2019-nCoV/USA_WA1/2020). Changes in cellular mRNA, protein or secreted cytokines were measured by qPCR, western blotting, or ELISA. SARS-CoV-2 levels were quantified by qPCR using primers for envelope (E) and nucleocapsid (N) protein. Data are expressed as mean ± SEM and statistical analysis was performed using paired t-tests or one-way ANOVA with Dunnett’s or Tukey’s multiple comparisons tests. Results: Treatment of colonic or ileal enteroids with the FXR agonist, OCA, increased expression of mRNA for the SARS-CoV-2 receptor, ACE2, by 2.1 ± 0.4 (n = 3; p = 0.08) and 2.3 ± 0.2 (n = 3; p < 0.05) fold, respectively. Similarly, treatment of T 84 cells with another FXR agonist, GW4064, increased expression of ACE2 mRNA with a maximal response of 1.8 ± 0.2 fold (n = 8; p < 0.01) occurring after 72 hrs. Increased mRNA was accompanied by a 2.3 ± 0.7 fold (n = 6; p < 0.01) increase in cellular protein expression and a 1.4 ± 0.1 fold (n = 9; p < 0.001) increase in ACE2 protein secretion into the apical medium. Effects of FXR on ACE2 expression were confirmed in monolayers of Caco-2 cells where GW4064 induced a 1.5 ± 0.1 fold (n = 3; p < 0.001) increase in mRNA for the receptor. GW4064 treatment did not affect mRNA levels for SARS-CoV-2 E or N protein in the infected Caco-2 cells. However, further experiments revealed that treatment with GW4064 inhibited release of the proinflammatory cytokine, IL-6, from either Caco-2 cells infected with SARS-CoV-2 or from T 84 cells treated with the viral mimic, polyinosinic-polycytidylic acid (poly (I:C)) (25 μg/ml) by 46 ± 12 % (n = 3, p < 0.05) and 35 ± 6 % (n = 8; p < 0.01), respectively. Conclusion: Our data suggest that FXR activation upregulates expression of ACE2 in intestinal and colonic epithelial cells but did not directly affect SARS-CoV-2 cellular levels. Rather, FXR activation inhibits viral-induced proinflammatory cytokine secretion and may therefore represent a good target for the development of new approaches to alleviate inflammatory diarrhoea associated with SARS-CoV-2 infection. This work was funded by grants from Science Foundation Ireland and the National Institutes of Health (DK047987). This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process." @default.
- W4378649969 created "2023-05-30" @default.
- W4378649969 creator A5011313274 @default.
- W4378649969 creator A5042075065 @default.
- W4378649969 creator A5044859707 @default.
- W4378649969 creator A5058458204 @default.
- W4378649969 creator A5061474320 @default.
- W4378649969 creator A5064532919 @default.
- W4378649969 creator A5068868147 @default.
- W4378649969 creator A5090560593 @default.
- W4378649969 date "2023-05-01" @default.
- W4378649969 modified "2023-09-27" @default.
- W4378649969 title "FXR activation enhances ACE2 expression and inhibits viral-induced IL-6 release from colonic epithelial cells in vitro: implications for gastrointestinal symptoms of SARS-CoV-2" @default.
- W4378649969 doi "https://doi.org/10.1152/physiol.2023.38.s1.5733615" @default.
- W4378649969 hasPublicationYear "2023" @default.
- W4378649969 type Work @default.
- W4378649969 citedByCount "0" @default.
- W4378649969 crossrefType "journal-article" @default.
- W4378649969 hasAuthorship W4378649969A5011313274 @default.
- W4378649969 hasAuthorship W4378649969A5042075065 @default.
- W4378649969 hasAuthorship W4378649969A5044859707 @default.
- W4378649969 hasAuthorship W4378649969A5058458204 @default.
- W4378649969 hasAuthorship W4378649969A5061474320 @default.
- W4378649969 hasAuthorship W4378649969A5064532919 @default.
- W4378649969 hasAuthorship W4378649969A5068868147 @default.
- W4378649969 hasAuthorship W4378649969A5090560593 @default.
- W4378649969 hasConcept C104317684 @default.
- W4378649969 hasConcept C126322002 @default.
- W4378649969 hasConcept C134018914 @default.
- W4378649969 hasConcept C153911025 @default.
- W4378649969 hasConcept C170493617 @default.
- W4378649969 hasConcept C203014093 @default.
- W4378649969 hasConcept C203862802 @default.
- W4378649969 hasConcept C2776914184 @default.
- W4378649969 hasConcept C2777067796 @default.
- W4378649969 hasConcept C2778690821 @default.
- W4378649969 hasConcept C2778938600 @default.
- W4378649969 hasConcept C55493867 @default.
- W4378649969 hasConcept C63932345 @default.
- W4378649969 hasConcept C71924100 @default.
- W4378649969 hasConcept C86339819 @default.
- W4378649969 hasConcept C86803240 @default.
- W4378649969 hasConceptScore W4378649969C104317684 @default.
- W4378649969 hasConceptScore W4378649969C126322002 @default.
- W4378649969 hasConceptScore W4378649969C134018914 @default.
- W4378649969 hasConceptScore W4378649969C153911025 @default.
- W4378649969 hasConceptScore W4378649969C170493617 @default.
- W4378649969 hasConceptScore W4378649969C203014093 @default.
- W4378649969 hasConceptScore W4378649969C203862802 @default.
- W4378649969 hasConceptScore W4378649969C2776914184 @default.
- W4378649969 hasConceptScore W4378649969C2777067796 @default.
- W4378649969 hasConceptScore W4378649969C2778690821 @default.
- W4378649969 hasConceptScore W4378649969C2778938600 @default.
- W4378649969 hasConceptScore W4378649969C55493867 @default.
- W4378649969 hasConceptScore W4378649969C63932345 @default.
- W4378649969 hasConceptScore W4378649969C71924100 @default.
- W4378649969 hasConceptScore W4378649969C86339819 @default.
- W4378649969 hasConceptScore W4378649969C86803240 @default.
- W4378649969 hasIssue "S1" @default.
- W4378649969 hasLocation W43786499691 @default.
- W4378649969 hasOpenAccess W4378649969 @default.
- W4378649969 hasPrimaryLocation W43786499691 @default.
- W4378649969 hasRelatedWork W1985296107 @default.
- W4378649969 hasRelatedWork W2027913950 @default.
- W4378649969 hasRelatedWork W2034583712 @default.
- W4378649969 hasRelatedWork W2050199314 @default.
- W4378649969 hasRelatedWork W2050423574 @default.
- W4378649969 hasRelatedWork W2063619316 @default.
- W4378649969 hasRelatedWork W2074821979 @default.
- W4378649969 hasRelatedWork W2101411396 @default.
- W4378649969 hasRelatedWork W2169225653 @default.
- W4378649969 hasRelatedWork W2956138079 @default.
- W4378649969 hasVolume "38" @default.
- W4378649969 isParatext "false" @default.
- W4378649969 isRetracted "false" @default.
- W4378649969 workType "article" @default.